NEW YORK, Feb. 24, 2014 /PRNewswire/ -- OTC Markets
Group Inc. (OTCQX: OTCM), operator of Open, Transparent and
Connected financial marketplaces, today announced that biOasis
Technologies Inc. (TSX.V: BTI; OTCQX: BIOAF), a Vancouver-based biopharmaceutical company
focused on developing a proprietary brain delivery platform
("Transcend") to enable existing and create new drugs that address
unmet medical needs in the treatment of brain diseases, has been
approved to trade on OTCQX®, the best marketplace with qualified
companies.
biOasis begins trading today on OTCQX International, a segment
of the OTCQX marketplace reserved for high-quality non-U.S.
companies that are listed on a qualified international exchange and
provide their home country disclosure to U.S. investors. U.S.
investors can find current financial disclosures and Real-Time
Level 2 quotes for the company on www.otcmarkets.com.
"We are pleased biOasis has chosen to trade on OTCQX," said
R. Cromwell Coulson, President and
CEO of OTC Markets Group. "biOasis is focusing on developing
solutions to one of the most important medical challenges of our
century: central nervous system disorders, including brain
cancer. We look forward to working with biOasis' management
team as they continue to execute on their strategic goals and
maximize the value of their public trading."
"Within the past few years we've made some significant
advancements around our Transcend platform, such that in the last
eighteen months we have attracted four top tier Pharmaceutical
companies to enter into collaboration agreements with us. In
addition to this, we've show in preclinical animal models that
using Transcend we can deliver many of the potentially hundreds of
the therapeutic biologics and small molecule drugs across the BBB
to potentially treat a host of neurological diseases that are
currently very problematic to treat, simply due to the brains
protective barrier (BBB)," said Rob
Hutchison Chairman and CEO of biOasis. "Our move to
the OTCQX is an important step for us as we are now ready to
commence executing on our global strategy within our
biotech/biopharmaceutical sector. We firmly believe this will
help us tell our story more widely within the investment community
not only in the U.S., but
globally."
Sanders Ortoli Vaughn-Flam Rosenstadt LLP serves as biOasis'
Principal American Liaison ("PAL") on OTCQX, responsible for
providing professional guidance on OTCQX requirements and U.S.
securities laws.
biOasis Technologies Inc. is a biopharmaceutical company
headquartered in Vancouver,
Canada. Based on Transcend, biOasis proprietary brain
delivery platform, the company is focused on creating new drugs
that can cross the blood-brain barrier to address unmet medical
needs in the treatment of brain diseases such as neurodegeneration,
metastatic cancer and metabolic diseases. For more
information about the company please visit www.bioasis.ca.
biOasis will trade in the U.S. on OTCQX under the symbol
"BIOAF."
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and
Connected financial marketplaces for 10,000 U.S. and global
securities. Through our OTC Link® ATS, we directly link a diverse
network of broker-dealers that provide liquidity and execution
services for a wide spectrum of securities. We organize these
securities into marketplaces to better inform investors of
opportunities and risks – OTCQX®, The Best Marketplace with
Qualified Companies; OTCQB®, The Venture Stage Marketplace with
U.S. Reporting Companies; and OTC Pink®, The Open Marketplace with
Variable Reporting Companies. Our data-driven platform enables
investors to easily trade through the broker of their choice at the
best possible price and empowers a broad range of companies to
improve the quality and availability of information for their
investors. To learn more about how we create better informed and
more efficient financial marketplaces, visit
www.otcmarkets.com.
OTC Link® ATS is operated by OTC Link LLC, member FINRA/SIPC and
SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
Logo: http://photos.prnewswire.com/prnh/20110118/MM31963LOGO
SOURCE OTC Markets Group Inc.